Borgeson Blake 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Oct 31, 2024
Insider Transaction Report
Form 4
Borgeson Blake
Director
Transactions
- Sale
Class A Common Stock
2024-10-29$6.72/sh−11,447$76,926→ 7,077,560 total
Footnotes (2)
- [F1]This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2023.
- [F2]This transaction was executed in multiple trades at prices ranging from $6.67 to $6.83. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.